Erik J. Tillman
0000-0003-3599-0297
Akero Therapeutics
2 papers found
Refreshing results…
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Endoplasmic Reticulum Homeostasis Is Modulated by the Forkhead Transcription Factor FKH-9 During Infection of Caenorhabditis elegans
Missing publications? Search for publications with a matching author name.